The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta‐analysis
BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee, YJ Lee… - Cancer, 2012 - infona.pl
BACKGROUND: The effects of the BRAF V600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
[引用][C] The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee, YJ Lee… - Cancer, 2011 - cir.nii.ac.jp
The association of the BRAFV600E mutation with prognostic factors and poor clinical
outcome in papillary thyroid cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
outcome in papillary thyroid cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
The association of the BRAF (V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee, YJ Lee… - Cancer, 2011 - europepmc.org
Background The effects of the BRAF (V600E) mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta-analysis
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee, YJ Lee… - Cancer, 2012 - snucm.elsevierpure.com
BACKGROUND: The effects of the BRAF V600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
[引用][C] The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer: A Meta-Analysis
TAEH KIM, YJOO PARK, BOY CHO, P DO JOON… - Cancer, 2012 - pascal-francis.inist.fr
The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical
Outcome in Papillary Thyroid Cancer: A Meta-Analysis CNRS Inist Pascal-Francis CNRS …
Outcome in Papillary Thyroid Cancer: A Meta-Analysis CNRS Inist Pascal-Francis CNRS …
[引用][C] The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta-analysis
TH Kim, YJ Park, JA Lim, DJ Park, HY Ahn, EK Lee… - Cancer, 2012 - elibrary.ru
The association of the BRAF (V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee… - Cancer, 2012 - pubmed.ncbi.nlm.nih.gov
Background The effects of the BRAF (V600E) mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
TH Kim, YJ Park, JA Lim, HY Ahn, EK Lee, YJ Lee… - Cancer, 2012 - infona.pl
BACKGROUND: The effects of the BRAF V600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …